SHONDA BOWERS: Open Payments
NPI 1205182359 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$789 in 39 payments from 19 companies in 2025. Trend: 2023 $82 · 2024 $20 · 2025 $789
Food & beverage: $789
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $139 |
| ABBVIE INC. | 5 | $92 |
| Lilly USA, LLC | 4 | $84 |
| Aimmune Therapeutics, Inc. | 3 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $61 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Lundbeck LLC | 1 | $32 |
| Xeris Pharmaceuticals, Inc. | 1 | $26 |
Products named: Wegovy, JARDIANCE, ZENPEP, CAPLYTA, REXULTI, Ozempic, UBRELVY, TRELEGY ELLIPTA.
Industry payments across NC — which companies pay providers there.
